中海油(00883.HK)擬向美國證交會申請撤銷所有類別註冊證券之註冊
中國海洋石油(00883.HK)公布,紐約證交所在今年10月12日向美國證交會提交了25表格,公司的美國存託股份下市在今年10月22日紐約股市休市之後生效。因此,公司計劃在今日(30日)向美國證交會提交15F表格,以撤銷其所有類別的註冊證券之註冊,並終止其根據《美國1934年證券交易法》(經修訂)第13(a)和15(d)條承擔的報告義務。
集團指,此後除非15F表格後續被撤回或退回,否則公司根據交易法承擔的所有報告義務都將自提交15F表格之日起暫停。撤銷註冊和終止其報告義務,預計將在遞交15F表格90天後生效。另外,公司美國存託股份計劃將會根據存托協議適時終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.